Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

A Partial Tender Offer of Englewood Lab by Cosmecca Korea

Cosmecca Korea Plans to Switch Listing from KOSDAQ to KOSPI

Korea M&A Highlight: Cosmecca Korea Acquires Englewood Lab

Focus on 5 Korean Small Cap, Cosmetics Stocks With Significant Growth in Operating Profit in 1Q 2023

Douglas Research Advisory

Event-Driven

<ul>
<li>On 3 March, Cosmecca Korea (241710 KS) announced another partial tender offer for its US subsidiary Englewood Lab (950140 KS).</li>
<li>Common shares allocated for tender offer is 3.31 million (16.7% of outstanding shares). Tender offer price is 13,000 won (7.4% higher than closing price on 2 March). </li>
<li>We are positive on Cosmecca Korea's partial tender offer of Englewood Lab.</li>
</ul>


On 3 March, Cosmecca Korea (241710 KS) announced another partial tender offer for its US subsidiary Englewood Lab (950140 KS).
Common shares allocated for tender offer is 3.31 million (16.7% of outstanding shares). Tender offer price is 13,000 won (7.4% higher than closing price on 2 March). 
We are positive on Cosmecca Korea's partial tender offer of Englewood Lab.


Another Partial Tender Offer for Englewood Lab by Cosmecca Korea